StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer BeneFIX [legacy through FY24] by Year

BeneFIX (coagulation factor IX) [legacy through FY24] — U.S. revenues ($M) ($M)

QuarterlyAnnual

Pfizer BeneFIX [legacy through FY24]: $200M in FY2024, down 11.1% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2024
200
Period ended Dec 31, 2024
Change on a year earlier
-11.1%
225 in FY2023
History
9 years
Since FY2016
Sources
8
Documents cited below

Where the FY2024 figure comes from

“|| BeneFIX | 381 | 424 | (10%) | (8%) | 200 | 225 | (11%) | 181 | 200 | (9%) | (5%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗

Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBeneFIX (coagulation factor IX) [legacy through FY24] — U.S. revenues ($M) ($M)Year on yearSource
FY2024Dec 31, 2024200-11.1%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2023Dec 31, 2023225+332.7%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2022Dec 31, 202252-10.3%Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2021Dec 31, 202158-6.5%Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2020Dec 31, 202062-13.9%Form 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2019Dec 31, 201972-12.2%Form 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2018Dec 31, 201882-67.6%Form 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗
FY2017Dec 31, 2017253-16.2%Form 8-K (Earnings / Guidance Release) (pfe-12312018xex99.htm, filed 2019-01-29) ↗
FY2016Dec 31, 2016302–Form 8-K (Earnings / Guidance Release) (pfe-12312017xex99.htm, filed 2018-01-30) ↗

Breakdown

What makes up beneFIX [legacy through FY24]

Cite this data

StockData. (2026). Pfizer BeneFIX [legacy through FY24] ($M), annual FY2016–FY2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/benefix-leg-us

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.